There was a small trend toward a better survival in the "stop" group but this was not significant (X2 = 1.47, P = 0.2).
← all excerpts
Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in Adults.
1
—
—